메뉴 건너뛰기




Volumn 60, Issue 4, 2009, Pages 260-267

The role of chemotherapy in advanced oral cavity cancer;El papel de la quimioterapia en el cáncer de la cavidad oral avanzado

Author keywords

Chemotherapy; Head and neck cancer; Oral cavity; Survival

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL;

EID: 67649494275     PISSN: 00016519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otorri.2009.01.005     Document Type: Article
Times cited : (1)

References (21)
  • 1
    • 37249056438 scopus 로고    scopus 로고
    • Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma long-term survival in a prospective, non-randomized study
    • Kessler P., Grabenbauer G., Leer A., Bloch-Birkholz A., Vairaktaris E., and Neukam F.W. Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma long-term survival in a prospective, non-randomized study. Br J Oral Maxillofac Surg 46 (2008) 1-5
    • (2008) Br J Oral Maxillofac Surg , vol.46 , pp. 1-5
    • Kessler, P.1    Grabenbauer, G.2    Leer, A.3    Bloch-Birkholz, A.4    Vairaktaris, E.5    Neukam, F.W.6
  • 3
    • 9744257104 scopus 로고    scopus 로고
    • Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up
    • Zorat P.L., Paccagnella A., Cavaniglia G., Loreggian L., Gava A., Mione C.A., et al. Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up. J Nat Cancer Inst 96 (2004) 1714-1717
    • (2004) J Nat Cancer Inst , vol.96 , pp. 1714-1717
    • Zorat, P.L.1    Paccagnella, A.2    Cavaniglia, G.3    Loreggian, L.4    Gava, A.5    Mione, C.A.6
  • 4
    • 33747326190 scopus 로고    scopus 로고
    • Phase II/III trial of induction chemotherapy (ICT) with cisplatin/5-fluorouracil (PF) vs. docetaxel (T) plus PF (TPF) followed by chemoradiotherapy (CRT) vs. CRT for unresectable locally advanced head and neck cancer (LAHNC)
    • Hitt R., Grau J., Lopez-Pousa A., Berrocal A., Sastre J., Belon J., et al. Phase II/III trial of induction chemotherapy (ICT) with cisplatin/5-fluorouracil (PF) vs. docetaxel (T) plus PF (TPF) followed by chemoradiotherapy (CRT) vs. CRT for unresectable locally advanced head and neck cancer (LAHNC). J Clin Oncol 23 (2005) 519S
    • (2005) J Clin Oncol , vol.23
    • Hitt, R.1    Grau, J.2    Lopez-Pousa, A.3    Berrocal, A.4    Sastre, J.5    Belon, J.6
  • 6
    • 0026569931 scopus 로고
    • A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck
    • Jacobs C., Lyman G., Vélez-García E., Sridhar K.S., Knight W., Hochster H., et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 10 (1992) 257-263
    • (1992) J Clin Oncol , vol.10 , pp. 257-263
    • Jacobs, C.1    Lyman, G.2    Vélez-García, E.3    Sridhar, K.S.4    Knight, W.5    Hochster, H.6
  • 7
    • 0026645077 scopus 로고
    • Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study
    • Forastiere A.A., Metch B., Schuller D.E., Ensley J.F., Hutchins L.F., Triozzi P., et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study. J Clin Oncol 10 (1992) 1245-1251
    • (1992) J Clin Oncol , vol.10 , pp. 1245-1251
    • Forastiere, A.A.1    Metch, B.2    Schuller, D.E.3    Ensley, J.F.4    Hutchins, L.F.5    Triozzi, P.6
  • 8
    • 0028359951 scopus 로고
    • Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (Cabo) versus cisplatin and 5-fluorouracil (Cf) versus cisplatin (C) in recurrent or metastatic squamous-cell carcinoma of the head and neck. A phase III Study of the EORTC Head and Neck-Cancer Cooperative Group
    • Clavel M., Vermorken J.B., Cognetti F., Cappelaere P., Demulder P.H.M., Schornagel J.H., et al. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (Cabo) versus cisplatin and 5-fluorouracil (Cf) versus cisplatin (C) in recurrent or metastatic squamous-cell carcinoma of the head and neck. A phase III Study of the EORTC Head and Neck-Cancer Cooperative Group. Ann Oncol 5 (1994) 521-526
    • (1994) Ann Oncol , vol.5 , pp. 521-526
    • Clavel, M.1    Vermorken, J.B.2    Cognetti, F.3    Cappelaere, P.4    Demulder, P.H.M.5    Schornagel, J.H.6
  • 10
    • 5644299741 scopus 로고    scopus 로고
    • Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma
    • Lindskog M., Spenger C., Jarvet J., Graslund A., and Kogner P. Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma. J Natl Cancer Inst 96 (2004) 1457-1466
    • (2004) J Natl Cancer Inst , vol.96 , pp. 1457-1466
    • Lindskog, M.1    Spenger, C.2    Jarvet, J.3    Graslund, A.4    Kogner, P.5
  • 11
    • 20644452264 scopus 로고    scopus 로고
    • Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): An intergroup trial of the eastern cooperative oncology group
    • Gibson M.K., Li Y., Murphy B., Hussain M.H.A., DeConti R.C., Ensley J., et al. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): An intergroup trial of the eastern cooperative oncology group. J Clin Oncol 23 (2005) 3562-3567
    • (2005) J Clin Oncol , vol.23 , pp. 3562-3567
    • Gibson, M.K.1    Li, Y.2    Murphy, B.3    Hussain, M.H.A.4    DeConti, R.C.5    Ensley, J.6
  • 12
    • 0036970170 scopus 로고    scopus 로고
    • Multidisciplinary approach in advanced cancer of the oral cavity: Outcome with neoadjuvant chemotherapy according to intention-to-treat local therapy. A phase II study
    • Grau J.J., Domingo J., Blanch J.L., Verger E., Castro V., Nadal A., et al. Multidisciplinary approach in advanced cancer of the oral cavity: Outcome with neoadjuvant chemotherapy according to intention-to-treat local therapy. A phase II study. Oncology 63 (2002) 338-345
    • (2002) Oncology , vol.63 , pp. 338-345
    • Grau, J.J.1    Domingo, J.2    Blanch, J.L.3    Verger, E.4    Castro, V.5    Nadal, A.6
  • 13
    • 0031105952 scopus 로고    scopus 로고
    • Intensive chemotherapy using cisplatin and fluorouracil followed by radiotherapy in advanced head and neck cancer
    • Zidan J., Kuten A., Rosenblatt E., and Robinson E. Intensive chemotherapy using cisplatin and fluorouracil followed by radiotherapy in advanced head and neck cancer. Oral Oncol 33 (1997) 129-135
    • (1997) Oral Oncol , vol.33 , pp. 129-135
    • Zidan, J.1    Kuten, A.2    Rosenblatt, E.3    Robinson, E.4
  • 14
    • 0030200639 scopus 로고    scopus 로고
    • Neoadjuvant and adjuvant chemotherapy in the multidisciplinary treatment of oral cancer stage III or IV
    • Grau J.J., Estape J., Blanch J.L., Vilalta A., Castro V., Biete A., et al. Neoadjuvant and adjuvant chemotherapy in the multidisciplinary treatment of oral cancer stage III or IV. Eur J Cancer B Oral Oncol 32B (1996) 238-241
    • (1996) Eur J Cancer B Oral Oncol , vol.32 B , pp. 238-241
    • Grau, J.J.1    Estape, J.2    Blanch, J.L.3    Vilalta, A.4    Castro, V.5    Biete, A.6
  • 15
    • 67649544973 scopus 로고    scopus 로고
    • Induction chemotherapy prior to surgery did not improve survival, but may reduce mandibulectomy over surgery alone in locally advanced squamous cell cancer of the oral cavity
    • Grau J.J. Induction chemotherapy prior to surgery did not improve survival, but may reduce mandibulectomy over surgery alone in locally advanced squamous cell cancer of the oral cavity. Cancer Treat Rev 29 (2003) 341-344
    • (2003) Cancer Treat Rev , vol.29 , pp. 341-344
    • Grau, J.J.1
  • 16
    • 0033854922 scopus 로고    scopus 로고
    • Survival results of neoadjuvant chemotherapy for advanced squamous cell carcinoma of the head and neck
    • Kohno N., Ikari T., Kawaida M., Tanaka K., Kawaura M., Kano S., et al. Survival results of neoadjuvant chemotherapy for advanced squamous cell carcinoma of the head and neck. Jpn J Clin Oncol 30 (2000) 253-258
    • (2000) Jpn J Clin Oncol , vol.30 , pp. 253-258
    • Kohno, N.1    Ikari, T.2    Kawaida, M.3    Tanaka, K.4    Kawaura, M.5    Kano, S.6
  • 17
    • 0026245749 scopus 로고
    • Locally advanced (stage III and IV) head and neck cancer: Westmead Hospital experience
    • Turner S.L., Kalnins I., Gebski V., and Tiver K.W. Locally advanced (stage III and IV) head and neck cancer: Westmead Hospital experience. Aust N Z J Surg 61 (1991) 744-752
    • (1991) Aust N Z J Surg , vol.61 , pp. 744-752
    • Turner, S.L.1    Kalnins, I.2    Gebski, V.3    Tiver, K.W.4
  • 18
    • 0027954416 scopus 로고
    • Lack of survival advantage in patients with advanced squamous cell carcinomas of the oral cavity receiving neoadjuvant chemotherapy prior to local therapy, despite achieving an initial high clinical complete remission rate
    • Hill B.T., and Price L.A. Lack of survival advantage in patients with advanced squamous cell carcinomas of the oral cavity receiving neoadjuvant chemotherapy prior to local therapy, despite achieving an initial high clinical complete remission rate. Am J Clin Oncol 17 (1994) 1-5
    • (1994) Am J Clin Oncol , vol.17 , pp. 1-5
    • Hill, B.T.1    Price, L.A.2
  • 19
    • 0027458280 scopus 로고
    • Overview of combined modality therapies for head and neck cancer
    • Dimery I.W., and Hong W.K. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 85 (1993) 95-111
    • (1993) J Natl Cancer Inst , vol.85 , pp. 95-111
    • Dimery, I.W.1    Hong, W.K.2
  • 20
    • 20044370435 scopus 로고    scopus 로고
    • Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: Final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial
    • Budach V., Stuschke M., Budach W., Baumann M., Geismar D., Grabenbauer G., et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: Final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 23 (2005) 1125-1135
    • (2005) J Clin Oncol , vol.23 , pp. 1125-1135
    • Budach, V.1    Stuschke, M.2    Budach, W.3    Baumann, M.4    Geismar, D.5    Grabenbauer, G.6
  • 21
    • 4344639820 scopus 로고    scopus 로고
    • Preliminary results of Radiation Therapy Oncology Group 97-03: A randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck
    • Garden A.S., Harris J., Vokes E.E., Forastiere A.A., Ridge J.A., Jones C., et al. Preliminary results of Radiation Therapy Oncology Group 97-03: A randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. J Clin Oncol 22 (2004) 2856-2864
    • (2004) J Clin Oncol , vol.22 , pp. 2856-2864
    • Garden, A.S.1    Harris, J.2    Vokes, E.E.3    Forastiere, A.A.4    Ridge, J.A.5    Jones, C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.